Evernimicin

Star0

DB06431ExperimentalSmall molecule

Investigated for use/treatment in bacterial infection.

Primary indication: Investigated for use/treatment in bacterial infection.Curator reviewed
Formula / weight: C₇₀H₉₇Cl₂NO₃₈ · 1631.42 g/mol (avg)
Code names: SCH-27899

Resolves to

Compound

UNII5X287491KHCAS109545-84-8ChEMBLCHEMBL263367

Structure

InChIKeyUPADRKHAIMTUCC-OWALTSPQSA-NSMILES

[H][C@]12CO[C@@H](O[C@]3([H])O[C@H](COC)[C@@H](O[C@]4([H])O[C@H](C)[C@H](OC)[C@H](O[C@]5([H])O[C@H](C)[C@@]6([H])O[C@]7(C[C@@H](O)[C@H](O[C@@]8([H])C[C@@H](O[C@@]9([H])C[C@@](C)([C@@H](OC)[C@H](C)O9)[N+]([O-])=O)[C@H](OC(=O)C9=C(OC)C(Cl)=C(O)C(Cl)=C9C)[C@@H](C)O8)[C@@H](C)O7)O[C@]6(C)[C@@H]5O)[C@H]4O)[C@H](O)[C@@H]3OC)[C@H](O)[C@]1([H])O[C@@]1(O2)OC[C@@H](OC(=O)C2=C(O)C=C(O)C=C2C)[C@]2([H])OCO[C@@]12[H]

Which companies are running trials of Evernimicin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account